Above image: countries with confirmed COVID-19 cases as of March 10th. Credit: CDC.gov
Below image: workers disinfecting streets in Xiaogon city, China. Credit: AFP via Getty Images.
It often takes adversity to spur creativity and innovation. Events that threaten our safety or shake our confidence alarm us, and often compel us to
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
Check back regularly for more.
We recently talked with Suzanne Kincaid, Chief Operating Officer at Aperio Clinical Outcomes, a CRO based in the Research Triangle Park area of North Carolina. We wanted to share these excerpts
There’s a new year underway. What can we do in 2020 to advance the success of clinical trials for sponsors, CROs, and the patients who ultimately benefit? At ArcheMedX, we firmly believe that a critical path to improving clinical trial readiness is improving your approach to training.
What’s wrong with the
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they are changing, and how they are likely to change. We wanted to share this excerpt from the conversation:
What are your predictions for how clinical operations will work— or should work—in the future?
Over the last year, we’ve been utilizing data analytics more and
We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck, about staffing clinical trial operations as part of our new interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
We wanted to share this excerpt from the conversation with Adam:
When you are working on the
When sponsors and contract research organizations (CROs) make decisions about which sites to include in a clinical trial, they too often rely on outdated historical data and show little confidence in the additional data the sites provide to them. For example, when completing the traditional site feasibility assessment sites may
The principal investigator (PI) meeting is a well-established (and expensive) tradition in the pharmaceutical industry. And, in our era of global programs, you might need to host multiple PI meetings: one for the Americas, one in Europe, one in Asia. Yet, no matter how many meetings you host, you will
One of the best analogies on learning that I ever learned came in a rather unlikely place.
I had just walked from my car to meet a PGA Top 100 golf instructor (John Dunigan), he was going to help me work through some issues with my game. 15 minutes into the
Kelly Ritch's addition better equips ArcheMedX to scale the capabilities it provides to transform clinical operations.
Charlottesville, VA (PRWEB) November 14, 2019
ArcheMedX, the company improving clinical trial readiness, today announced the expansion of its senior leadership team. To support increasing demand for Ready, the company’s clinical trials platform, with sponsors and